Journal
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume 10, Issue 7, Pages -Publisher
WILEY
DOI: 10.1161/JAHA.120.019944
Keywords
dilated cardiomyopathy; hypertrophic cardiomyopathy; modifier genes; variable expressivity; variant burden
Categories
Funding
- National Institutes of Health/National Heart, Lung, and Blood Institute [R01HL128075, U01HL131914]
- National Institutes of Health/National Human Genome Research Institute [U01HG008673]
- American Heart Association [18CDA34110460]
Ask authors/readers for more resources
By comparing protein coding variations in the genomes of familial cases of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), it was found that individuals with DCM had more nonsynonymous single-nucleotide variants (nsSNVs) in cardiomyopathy genes. These variants were significantly associated with reduced left ventricular ejection fraction and increased left ventricular diameter in individuals with DCM, but not in those with HCM. This suggests that increased variation in cardiomyopathy genes predisposes individuals to DCM and worsens disease severity.
Background Inherited cardiomyopathies display variable penetrance and expression, and a component of phenotypic variation is genetically determined. To evaluate the genetic contribution to this variable expression, we compared protein coding variation in the genomes of those with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Methods and Results Nonsynonymous single-nucleotide variants (nsSNVs) were ascertained using whole genome sequencing from familial cases of HCM (n=56) or DCM (n=70) and correlated with echocardiographic information. Focusing on nsSNVs in 102 genes linked to inherited cardiomyopathies, we correlated the number of nsSNVs per person with left ventricular measurements. Principal component analysis and generalized linear models were applied to identify the probability of cardiomyopathy type as it related to the number of nsSNVs in cardiomyopathy genes. The probability of having DCM significantly increased as the number of cardiomyopathy gene nsSNVs per person increased. The increase in nsSNVs in cardiomyopathy genes significantly associated with reduced left ventricular ejection fraction and increased left ventricular diameter for individuals carrying a DCM diagnosis, but not for those with HCM. Resampling was used to identify genes with aberrant cumulative allele frequencies, identifying potential modifier genes for cardiomyopathy. Conclusions Participants with DCM had more nsSNVs per person in cardiomyopathy genes than participants with HCM. The nsSNV burden in cardiomyopathy genes did not correlate with the probability or manifestation of left ventricular measures in HCM. These findings support the concept that increased variation in cardiomyopathy genes creates a genetic background that predisposes to DCM and increased disease severity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available